关于自身免疫性痴呆症及其前体的最新情况
1Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Von-Siebold-Str. 5, Göttingen 37075, Germany.
Behavioural brain research
|January 31, 2025
概括
自免疫性痴呆症涉及新的神经抗体影响认知功能. 了解这些自身抗体及其机制对于开发针对性治疗和指导方针对于这种新出现的疾病至关重要.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 自身免疫性痴呆是一种新兴的神经疾病.
- 新型神经自身抗体越来越多地与痴呆症及其前体有关.
- 这些自身抗体在认知障碍中的确切作用需要进一步阐明.
研究的目的:
- 审查与认知障碍相关的已知和新出现的自身抗体.
- 描述这些抗体的致病机制.
- 讨论自身免疫性痴呆症的诊断和治疗方法.
主要方法:
- 对神经自身抗体和认知障碍研究的文献综述.
- 病原性机制的分析,包括补剂依赖性细胞毒性和受体对抗性.
- 在痴呆症和自身免疫性脑炎中讨论已确定的和新的自身抗体.
主要成果:
- 已经确定的抗体,如LGI1和NMDAR抗体是致病的.
- 机制包括补充依赖的细胞毒性,受体内化和突触变化.
- 各种自身抗体与神经退行性痴呆症和具有痴呆症的自身免疫性脑炎有关.
结论:
- 自身免疫性痴呆是一种异质的实体,具有多样化的自身抗体关联.
- 需要进一步的研究,以了解抗体的意义,并制定治疗指南.
- 免疫疗法反应和测试方法需要继续调查.
相关概念视频
Autoimmune Disorders
379
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
379
Alzheimer's Disease: Overview
437
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437
Dementia
92
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
92
Alzheimer's Disease: Treatment
158
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
158
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Parkinson's Disease: Overview
447
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447


